Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05770752
Other study ID # P-2022-462
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2023
Est. completion date October 2024

Study information

Verified date November 2023
Source Rigshospitalet, Denmark
Contact Lene Thorup, MD
Phone +4535457845
Email lene.thorup.01@regionh.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study wil examine the effect of altered intrathoracic pressure on lymphatic function, by investigating the lymphatic vessels in the lower limb during mechanical ventilation. The lymphatic function will be examined using Near-Infrared Fluorescence Imaging.


Description:

This study wil examine the effect of altered intrathoracic pressure on lymphatic function. This will be done by investigating peripheral lymphatic vessels on patients undergoing surgery for malformations of the jaw who are being mechanically ventilated. Subjects will be examined on two occasions. One to establish baseline function, and one during surgery following a ventilation protocol with altered PIP and PEEP.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date October 2024
Est. primary completion date March 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Patients undergoing surgery for jaw malformations - Age > 18 years - Informed consent - Cardiopulmonary healthy Exclusion Criteria: - History of Cardiac disease - History of pulmonary disease - History of lymphatic disease - Peripheral edema - Chronic infectious disease - Age > 30 years - BMI > 30

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Elevated pressure ventilation
Elevated pressure ventilation is defined as a raise in PIP and PEEP by 10 cmH2O from each patients original pressure setting, although never higher than a PIP of 30 cmH2O.

Locations

Country Name City State
Denmark Copenhagen University Hospital Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peripheral lymphatic velocity (centimeters/second) Peripheral lymphatic fluid velocity (centimeters/second) will be calculated based upon NIRF sequences. 3 hours
Primary Peripheral lymphatic frequency (contractions/minute) Peripheral lymphatic contraction frequency (contractions/minute) will be calculated based upon NIRF sequences. 3 hours
See also
  Status Clinical Trial Phase
Completed NCT04595448 - Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation